Paradoxically, while high DLL3 expression appears to suppress Notch signaling in SCLC, reduced DLL3 levels may disrupt the typical lateral inhibition observed in Notch/DLL interactions, suggesting a complex regulatory mechanism (23). This evidence concerns the gene DLL3 and small cell lung carcinoma.